Botox 100 unit vials
Ended Awarded
- Contract number
- SPE2DR26FFKS4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,888
Award facts
- Contract value 100% obligated
- $1,888.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 100-unit vials of BOTOX, valued at $1,888.36. This delivery order, issued on November 17, 2025, with an ultimate completion date of December 9, 2025, operates under a firm fixed-price structure with no set-aside designation. The award is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion Defense Logistics Agency acquisition strategy designed to provide comprehensive pharmaceutical and medical supply sourcing for Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group holds a single-award Indefinite Delivery Contract under this program, designated as SPE2DR, with a $500 million ceiling value and completion date of December 31, 2036.
DMS Pharmaceutical Group has demonstrated substantial capability as a critical pharmaceutical supplier for federal military medical operations, with numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division. The company's product portfolio encompasses branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables, positioning it to fulfill diverse and specialized pharmaceutical requirements across the military healthcare system. This BOTOX delivery order represents one of multiple purchases issued to the contractor, reflecting its established performance and competitive standing within the federal pharmaceutical supply chain as a woman-owned small business contractor.
Quick answers
Who was awarded contract SPE2DR26FFKS4?
SPE2DR26FFKS4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26FFKS4 worth?
The government has obligated $1,888 on SPE2DR26FFKS4.
Is contract SPE2DR26FFKS4 an order under another contract?
Yes. SPE2DR26FFKS4 is a delivery order under SPE2DR25D9212, an indefinite delivery contract.
Was contract SPE2DR26FFKS4 competed?
The extent of competition for SPE2DR26FFKS4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award